Real-World Experience with Carbidopa-Levodopa Extended-Release Capsules (Rytary(®)): Results of a Nationwide Dose Conversion Survey

BACKGROUND: The introduction of carbidopa-levodopa extended-release (CD-LD ER) capsules (Rytary®) did not go as smoothly as expected, largely due to difficulty around dose conversion from available immediate-release (IR) levodopa (LD) formulations. The dose conversion table in the CD-LD ER prescribi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hauser, Robert A., Banisadr, Ghazal, Vuong, Kara, Freilich, David, Fisher, Stanley, D'Souza, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914099/
https://www.ncbi.nlm.nih.gov/pubmed/33688424
http://dx.doi.org/10.1155/2021/6638088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914099/
https://www.ncbi.nlm.nih.gov/pubmed/33688424
http://dx.doi.org/10.1155/2021/6638088

Ejemplares similares